Order Article Reprints

Omole EB, Aijaz I, Ellegate J Jr., Isenhart E, Desouki MM, Mastri M, Humphrey K, Dougherty EM, Rosario SR, Nastiuk KL, et al. Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers. Cancers. 2022; 14(19):4724. https://doi.org/10.3390/cancers14194724

Omole, Emmanuel B., Iqbal Aijaz, James Ellegate, Jr., Emily Isenhart, Mohamed M. Desouki, Michalis Mastri, Kristen Humphrey, Emily M. Dougherty, Spencer R. Rosario, Kent L. Nastiuk, and et al. 2022. "Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers" Cancers 14, no. 19: 4724. https://doi.org/10.3390/cancers14194724

Omole, E. B., Aijaz, I., Ellegate, J., Jr., Isenhart, E., Desouki, M. M., Mastri, M., Humphrey, K., Dougherty, E. M., Rosario, S. R., Nastiuk, K. L., Ohm, J. E., & Eng, K. H. (2022). Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers. Cancers, 14(19), 4724. https://doi.org/10.3390/cancers14194724